tirzepatide vs semaglutide efficacy weight loss Dynamics and Health Burden Changes with versus tirzepatide weight loss efficacy vs

Pain at injection site semaglutide is a recognized local adverse reaction affecting approximately 1.2-1.4% of patients using this GLP-1 receptor agonist for type 2 diabetes or weight management

This can lead to infections or other adverse reactions

25 Given concerns that skeletal muscle loss may predispose patients to long-term metabolic complications, including sarcopenia, it is recommended that individuals undergoing treatment with GLP-1 RAs receive adequate protein intake and appropriate micronutrient supplementation to preserve muscle mass and function, thereby maximizing the clinical benefits of therapy

Colleagues Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas

Shifting your mindset around food and weight loss is also crucial